FindTrial
Sign In

Evaluating the Value of Novel Detection Techniques in the Diagnosis of T-cell Lymphoma

Research on the Clinical Value of Flow Cytometry in the Diagnosis of T-cell Lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122847
Enrollment
Unknown
Registered
2026-04-20
Start date
2025-09-30
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mature T-cell lymphoma

Interventions

Observation group:None

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with aberrant phenotypic T-cell clones detected by peripheral blood or tissue flow cytometry in the Hematology Laboratory of Huashan Hospital, Fudan University, between January 2020 and May 2025, regardless of gender or age.

Exclusion criteria

Exclusion criteria: 1. Those without a definite clinical diagnosis; 2. Those lacking TCR rearrangement examination data; 3. Those with insufficient pathological data or an unclear pathological diagnosis.

Design outcomes

Primary

MeasureTime frame
the expression level and intensity of flow cytometric antigens;the FSC/SSC parameters;The percentage of aberrant phenotypic T-cells within lymphocytes;—

Countries

China

Contacts

Public ContactWang Qian

Huashan Hospital, Fudan University

wangqian2004_2@126.com+86 21 5288 7102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026